33 years biotechnology industry experience beginning at Genentech; serial entrepreneur co-founding 9 companies in molecular testing, diagnostic/medical device and therapeutics, led 5 products through FDA 510(k), taking several companies public. PhD in Molecular Biology and Biotechnology, MBA from Northwestern University’s Kellogg School of Business.

OUHSC George Lynn Cross Research Professor, over 40 years research in molecular mimicry and immunity, inventor of technology. Over 100+ peer-reviewed publications in high impact journals such as Nature Medicine, Journal of Immunology, Journal of Clinical Microbiology, Neuropsychopharmacology.

45+ years experience in corporate finance and accounting, Began career at Touche Ross & Co. in 1962. Controller at Elgin National & Columbia Pictures, CFO at Wilkinson Sword, Financial consultant to numerous companies including two biotechnology companies including one publicly traded biotechnology company.

30+ years experience in building successful diagnostic and therapeutic companies from company inception through successful exits, including a $230M exit to Roche. Ph.D. in Biochemistry from Oklahoma State University and postdoctoral training at Dartmouth Medical School.

30 years life science product commercialization in start-ups, a mid-cap and 3 Fortune 500 companies. Management of marketing and sales teams for Johnson & Johnson, Abbott Diagnostics and Cordis Cardiology. Directed marketing Becton Dickinson’s $210M molecular diagnostics business.